Should we use drugs to fight obesity in children?
I’m not a doctor, nor do I have a background in medicine. But I am a fairly avid reader of medical news and reports, which is why I was surprised by the latest recommendation by an influential doctor’s group regarding the battle against childhood obesity.
In the July edition of Pediatrics, the American Academy of Pediatrics replaces its earlier stance which recommended cholesterol fighting drugs called statins for children 10 years of age or older who had been unsuccessful at losing weight, with new advice to prescribe pills to children as young as 8 who have an excess of LDL or bad cholesterol, as well as other risk factors.
With one-third of American kids classified as overweight and roughly 17 percent obese, the doctors’ group is taking an assertive stance against heart disease, which is the number one killer in the U.S. and is increasingly being shown to begin early in life.
“If we are more aggressive about this in childhood, I think we can have an impact on what happens later in life … and avoid some of these heart attacks and strokes in adulthood,” Dr. Stephen Daniels, a Denver area pediatrician and member of the academy’s nutrition committee, told the Associated Press.
For overweight kids with insufficient amounts of HDL or good cholesterol, the academy still recommends exercise, nutritional counseling and weight loss as the first step.
I wonder: why isn’t that still the first step for all overweight and obese children? I would think it’s when they are young, malleable, and still under the control of adults, that lifestyle changes like healthy eating and regular physical activity could be implemented and could even stick.
Giving kids drugs to tackle weight and health risk factors only teaches them to throw pills at a problem, which is a lesson far too many Americans have learned; it does not need to be passed on to even younger generations. What’s more, the academy’s recommendation (and again, I’m not a doctor) not only sidesteps the root of the problem, but it also could incur new ones, like liver damage, a byproduct of long-term sustained use of statins.
Naomi Dillon, Senior Editor
